Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,709.90
0.83%
Copper
4.07
(0.07%)
Oil
71.24
1.51%
Bitcoin
98,138.16
0.38%
FTSE 100
8,262.10
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Genetic Technologies Ltd

GTG

ASX

Genetic Technologies Limited (GTG) is a diagnostics company specialising in genomics-based tests for health, wellness, and serious diseases through its geneType and EasyDNA brands. GTG provides cancer predictive testing and assessment tools designed to assist physicians in enhancing health outcomes for individuals worldwide. By leveraging advanced genetic insights, GTG aims to empower healthcare providers with the information needed to offer personalised care and proactive health management. Through its innovative approach, the company strives to make a significant impact on global health by improving early detection and prevention strategies for various conditions.

Latest Posts

Line Chart with Gradient
Price
$0.039
0 (0%)
At Close 22/11 (AEST)
Related Companies
AFT PHARMACEUTICALS LIMITED
$AFP
PATRYS LIMITED
$PAB
PROBIOTEC LIMITED
$PBP
LTR PHARMA LIMITED
$LTP
ANATARA LIFESCIENCES LTD
$ANR

Leave a Comment on GTG


Comments for GTG

    Latest Posts

    genetic-technologies-asx-gtg-offers-non-renounceable-entitlement-offer-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) offers non-renounceable entitlement offer

    Company aims to raise up to $3.88 million through new share and option offer

    August 2, 2024
    genetic-technologies-asx-gtg-expands-genetype-tests-to-canada-and-new-zealand-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) expands geneType tests to Canada and New Zealand

    Company introduces genetic risk assessment tests to new markets and reports 500% increase in sales

    July 9, 2024
    genetic-technologies-asx-gtg-expands-operational-capacity-in-north-america-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) expands operational capacity in north america

    Launches testing operations for geneType disease risk assessments at US based, world-leading genetic laboratory

    June 18, 2024
    genetic-technologies-asx-gtg-announces-distribution-agreement-with-stayhealthy-for-multi-risk-test-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) announces distribution agreement with Stayhealthy for multi-risk test

    Partnership to bring innovative health test to broader audience in North America

    June 5, 2024
    genetic-technologies-asx-gtg-launches-revolutionary-genetype-test-covering-100-risk-of-breast-and-ovarian-cancer-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) launches revolutionary genetype test covering 100% risk of breast and ovarian cancer

    New geneType Comprehensive Risk Assessment test provides complete understanding of cancer risk profile

    May 29, 2024
    genetic-technologies-asx-gtg-signs-b2b-sales-marketing-deal-with-wellworks-for-you-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) signs b2b sales & marketing deal with wellworks for you

    Partnership to provide geneType tests to 2 million U.S. employees

    May 6, 2024
    genetic-technologies-asx-gtg-offers-16-8-million-shares-and-warrants-in-public-offering-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) offers 16.8 million shares and warrants in public offering

    Plans to use proceeds for driving revenue, expanding into new markets, and launching comprehensive risk assessment test

    April 24, 2024
    Genetic Technologies (ASX: $GTG) offers 16.8 million shares and warrants in public offering
    Materials $GTG

    Genetic Technologies (ASX: $GTG) offers 16.8 million shares and warrants in public offering

    Plans to use proceeds for driving revenue, expanding into new markets, and launching comprehensive risk assessment test

    April 23, 2024
    genetic-technologies-asx-gtg-to-pilot-genetype-in-breast-screen-centres-across-the-u-s-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) to pilot genetype in breast screen centres across the U.S.

    Establishing clinical implementation study with leading clinicians to streamline breast cancer risk assessment

    April 11, 2024
    genetic-technologies-asx-gtg-to-develop-worlds-most-advanced-comprehensive-risk-test-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) to develop world's most advanced comprehensive risk test

    Company's latest innovation to revolutionize personalized healthcare and genetic testing market

    March 22, 2024
    genetic-technologies-asxgtg-updates-share-consolidation-timetable-gtg
    Health Care $GTG

    Genetic Technologies (ASX:GTG) updates share consolidation timetable

    Company advises further change to timetable for 100:1 share consolidation

    December 19, 2023
    genetic-technologies-asx-gtg-requests-trading-halt-for-strategic-review-gtg
    Health Care $GTG
    Genetic Technologies (ASX: $GTG) requests trading halt for strategic reviewEvaluating strategic options and operational review, linked to July 2024 fundraising efforts

    October 17, 2024

    genetic-technologies-asx-gtg-suspends-gtgn-shares-from-quotation-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) suspends GTGN shares from quotation

    Security class GTGN suspended due to non-renounceable entitlement offer

    September 16, 2024

    genetic-technologies-asx-gtg-closes-entitlement-offer-raising-324648-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) closes entitlement offer raising $324,648

    Company receives strong participation from eligible shareholders

    September 11, 2024

    genetic-technologies-asx-gtg-partners-with-cancerlq-for-expanded-clinical-risk-prediction-gtg
    Health Care $GTG

    Genetic Technologies (ASX: $GTG) partners with CancerlQ for expanded clinical risk prediction

    Partnership with CancerlQ to enhance geneType Risk Assessment Test portfolio and access to US healthcare systems

    September 11, 2024

    GTG

    $GTG

    Genetic Technologies (ASX: $GTG) offers non-renounceable entitlement offer

    Company aims to raise up to $3.88 million through new share and option offer

    GTG

    $GTG

    Genetic Technologies (ASX: $GTG) expands geneType tests to Canada and New Zealand

    Company introduces genetic risk assessment tests to new markets and reports 500% increase in sales

    GTG

    $GTG

    Genetic Technologies (ASX: $GTG) expands operational capacity in north america

    Launches testing operations for geneType disease risk assessments at US based, world-leading genetic laboratory

    GTG

    $GTG

    Genetic Technologies (ASX: $GTG) announces distribution agreement with Stayhealthy for multi-risk test

    Partnership to bring innovative health test to broader audience in North America

    GTG

    $GTG

    Genetic Technologies (ASX: $GTG) launches revolutionary genetype test covering 100% risk of breast and ovarian cancer

    New geneType Comprehensive Risk Assessment test provides complete understanding of cancer risk profile

    GTG

    $GTG

    Genetic Technologies (ASX: $GTG) signs b2b sales & marketing deal with wellworks for you

    Partnership to provide geneType tests to 2 million U.S. employees

    GTG

    $GTG

    Genetic Technologies (ASX: $GTG) offers 16.8 million shares and warrants in public offering

    Plans to use proceeds for driving revenue, expanding into new markets, and launching comprehensive risk assessment test

    GTG

    $GTG

    Genetic Technologies (ASX: $GTG) offers 16.8 million shares and warrants in public offering

    Plans to use proceeds for driving revenue, expanding into new markets, and launching comprehensive risk assessment test

    GTG

    $GTG

    Genetic Technologies (ASX: $GTG) to pilot genetype in breast screen centres across the U.S.

    Establishing clinical implementation study with leading clinicians to streamline breast cancer risk assessment

    GTG

    $GTG

    Genetic Technologies (ASX: $GTG) to develop world's most advanced comprehensive risk test

    Company's latest innovation to revolutionize personalized healthcare and genetic testing market

    Load More
    No More Posts
    Related Companies
    NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
    $NSB
    PACIFIC EDGE LIMITED
    $PEB
    WELLFULLY LIMITED
    $WFL
    HEXIMA LIMITED.
    $HXL
    INVION LIMITED
    $IVX

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions